Prof Roland Kontermann
Dr JORG EBERHARDT
Dr Jorg Eberhardt and colleagues will be responsible for the student´s training on dermato-oncological topics within the pharmaceutical industry.
DR Birgit Schoeberl
Dr Birgit Schoeberl , PhD is Senior Vice President Research Merrimack Pharmaceuticals.
MEL-PLEX Project 7
Dr Marco Liberati
Dr Marco Liberati coordinated the EMMA Italian node for the breeding of wt and gm mice, stayed at the JAX laboratory and other locations.
He has more than 30 years of experience in the field of laboratory animal research facility management, animal care and project management.
MEL-PLEX Project 9
Prof Keith Flaherty
Prof Keith Flaherty (Director of developmental therapeutics, Associate Professor of Medicine at Harvard medical school) will supervise students in his group in the Melanoma Program and Termeer Center for Targeted Therapy, which Prof Flaherty directs.
Prof Flaherty’s group consists of a clinical research staff comprised of research nurses, data managers, and regulatory coordinators. This unit is housed in the Yawkey outpatient centre at MGH.
MEL-PLEX Project 13
Prof Michal Lotem
Dr Michal Lotem, MD, Head, Center for Melanoma and Cancer Immunotherapy, acquired her MD in Sackler School of Medicine Tel Aviv University. She is a board certified Dermatologist and a Clinical Oncologist. She spent a research fellowship with Dr Steven Rosenberg, Surgery Branch, NCI, NIH, Bethesda, Md, USA (2002-2004) and a visiting fellowship at the research labs of Prof Ronald Levy, Stanford School of Medicine, CA, USA.
Dr Lotem combines active clinical work and research projects focusing on immune checkpoint candidates in cancer therapy. In addition to immunotherapy regimens her lab is preparing and delivering Adoptive cell therapy using TILs.
The Hadassah Medical Organisation is a tertiary referral center and Israel most renowned medical center that combines medical work with basic research of the highest level.
MEL-PLEX Project 14
Dr Feriel Hacini-Rachinel
Dr Feriel Hacini-Rachinel is the “Inflammation-Immunity” Unit Manager and possesses expertise in skin cancer, drug development and evaluation, in vivo models.
MEL-PLEX Project 15